Summary Using two instruments (SF-6D and EQ-5D) to estimate quality adjusted life years (QALYs), we conducted an economic evaluation of a 12-month randomized controlled trial with a 12-month follow-up study in older women to evaluate the value for money of two doses of resistance training compared with balance and tone classes. We found that the incremental QALYs estimated from the SF-6D were two-to threefold greater than those estimated from the EQ-5D. Introduction Decision makers must continually choose between existing and new interventions. Hence, economic evaluations are increasingly prevalent. The impact of qualityadjusted life year (QALY) estimates using different instruments on the incremental cost-effectiveness ratios (ICERs) is not well understood in older adults. Thus, we compared ICERs, in older women, estimated by the EuroQol-5D (EQ-5D) and the Short Form-6D (SF-6D) to discuss implications on decision making. Methods Using both the EQ-5D and the SF-6D, we compared the incremental cost per QALY gained in a randomized controlled trial of resistance training in 155 community-dwelling women aged 65 to 75 years. The 12-month randomized controlled trial included a subsequent 12-month follow-up. Our focus, the follow-up study, included 123 of the 155 participants from the Brain Power study; 98 took part in the economic evaluation (twiceweekly balance and tone exercises, n=28; once-weekly Specific remarks Decision makers must continually choose between existing and new interventions. The incremental quality-adjusted life years estimated from the SF-6D were two-to threefold greater than those estimated from the EQ-5D. Given the large magnitude of difference, the choice of preference-based utility instrument may substantially impact health care decisions.
Introduction
A primary goal of the health care system is to maximize health benefit given that resources are finite. Decision makers must continually choose between existing management/programs and new interventions for specific clinical problems [1, 2] . To guide health policy decisions, economic evaluations that evaluate the incremental costs and effects of one strategy when compared to another are increasingly prevalent [3, 4] . Two most commonly used economic evaluations in health care are cost-effectiveness and cost-utility analyses. A widely accepted strength of cost-utility analyses is that it provides a common metric with which to compare existing and new health care interventions with standard of care. The dogma is that QALYs permit comparison across conditions and populations. For this to be true, it would mean that the differences in methodology and valuations used to estimate qualityadjusted life years (QALYs) were insignificant [5, 6] . QALYs are defined as the benefit of a health intervention in terms of time in a series of quality-weighted health states, in which the quality weights reflect the desirability of living in the particular health state, typically anchored at "perfect" health (weighted 1.0) and dead (weighted 0.0) [7] . The quality weights spent in each state are multiplied by the time spent in each state. The total number of QALYs for that time period is the sum of all these products. In studies that compared utility scores, few evaluated the impact of different preference-based utility instruments and the incremental cost-effectiveness ratio on decision making [8] . Of those that did, the conclusion was that although the incremental cost-effectiveness ratios (ICERs) differ based on the QALY estimate method used, the implications on decision making were minimal [2, 8, 9] .
This broad-spanning claim-that QALY estimates using different instruments have a limited bearing on ICERs in the context of decision making-warrants careful scrutiny. Is that true across all, if any, conditions? Recently, investigators reviewed the relative merits of various methods used to elicit health state utility values for estimating QALYs. Two widely used indirect techniques are the EuroQol-5D (EQ-5D) [10, 11] and the Short Form 6D (SF-6D) [12, 13] . In a key paper, Joore and colleagues [14] found the likelihood of accepting the incremental cost-utility ratio was substantially greater for patient groups with mild conditions when the EQ-5D was used, but for patient groups with worse conditions, the SF-6D resulted in a greater likelihood of accepting the incremental cost-utility ratio. These findings highlight that the probability of funding a program or intervention depends on the instrument used. However, what was not addressed by Joore and colleagues [14] is which instrument is most responsive in the respective populations. Hence, further research is needed to determine the construct validity of these instruments in population-specific settings as Marra and colleagues have done in rheumatoid arthritis [15] .
Decision makers will continue to make many difficult decisions about health resource allocation in the future. To address the question of which quality of life measure might provide more valid data, we used both the EQ-5D and the SF-6D in a cost-utility analysis. Our objective was to compare the incremental cost-effectiveness ratios estimated from QALYs calculated using the EQ-5D and the SF-6D to discuss potential implications for decision making. We designed a concurrent, prospective economic analysis using individual level data on cost and effectiveness outcomes as part of the Brain Power study, a three-arm randomized controlled trial [16] . The main outcomes of the clinical trial and the economic evaluations are reported elsewhere [16, 17] . Hence, our purpose was to add a novel population to the few studies that have made these condition-specific comparisons. In turn, this will provide a basis for recommending condition-specific methods for QALY estimation that may be more appropriate for decision makers.
Methods

Sample
We previously reported details of the Brain Power randomized controlled trial and follow-up study [16, 18] . Briefly, the original study sample included 155 community-dwelling women aged 65 to 75 years. Participants enrolled in Brain Power had a Mini Mental State Examination score ≥24/ 30 (i.e., were cognitively intact) and visual acuity 20/40 or better with or without corrective lenses. Participants who were excluded were those unable to write and speak English, were partaking in resistance training in the last 6 months, had a current medical condition for which exercise is contraindi-cated, had a neurodegenerative disease, were taking cholinesterase inhibitors, were being treated currently for depression, or were on hormone replacement therapy during the previous 12 months. The interventions for the Brain Power study included three participant groups: once-weekly resistance training, twice-weekly resistance training and the control group, twice-weekly balance and tone classes (comparator). The resistance training program used a progressive, highintensity protocol. The balance and tone program consisted of stretching exercises, range-of-motion exercises, basic corestrength exercises including kegels (pelvic floor exercises), balance exercises, and relaxation techniques. All classes were 60 min in duration, with a 10-min warm-up, 40 min of core content, and a 10-min cooldown period.
The 12-month follow-up study sample included 135 community-dwelling women aged 65 to 75 years who completed the 12-month intervention. Of these, 89 participants completed the EQ-5D at all three time points, and 127 participants completed the SF-36 at all three time points. We used these two complete case sets for all data analyses.
Instruments
Health care costs-health resource utilization questionnaire
We have previously described our collection of health care costs for the Brain Power economic evaluation and follow-up study [17, 18] . Briefly, the health resource utilization questionnaire asked participants to report the following visits over a specified time period: (1) health care professionals, (2) admissions or visits to hospital, and (3) laboratory work. The health resource questionnaire is described and supported in previous studies [19, 20] . In total, we collected 9 months of data from the Brain Power study on associated health care resource use using a 9-month time horizon and a 21-month time horizon for the follow-up study. Participants recalled their health care resource use every 3 months during the 12-month follow-up study. A detailed list of cost items collected was previously reported [17] . We estimated total health carerelated costs over the 9 and 21 months from a Canadian health care system perspective and presented all costs in 2008 Canadian dollars. We costed all items using the 2008 BC Ministry of Health Fee Payment Schedule [21] and the Vancouver General Hospital Fully Allocated Cost Model developed by Marra and colleagues [17] .
EuroQol-5D
The EQ-5D is a generic preference-based utility instrument developed by the EuroQol Group and is one of the most commonly used instruments [10, 11] . This five-item questionnaire includes the following domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/ depression with each attribute having three possible options: (1) no problems, (2) some problems, and (3) major problems. These options combine for a total possible 243 health states identified. Individuals' preferences for health states defined by the EQ-5D were measured using the TTO technique on a random sample adult population living in the UK (n=3,000) [22] . Scoring is anchored such that 0 represents preference for death, 1.0 represents the preference for a state of "full health," and less than 0 represents health states that are perceived to be worse than death. Health states less than 0 are possible for the EQ-5D (range, −0.594 to 1.00) [22] . Participants rated their health on the "day" the questionnaire was administered.
Short Form-6D
The SF-6D is also a generic preference-based utility instrument that is based on a widely used health-related quality-of-life questionnaire, the Short Form 36 [12] . The SF-36 can be used to calculate a utility score for the SF-6D. This six-item questionnaire contained six domains that include: physical functioning, role limitations, social functioning, pain, mental health, and vitality. Each attribute contains four to six levels that account for the 18,000 unique health states captured by the SF-6D. Unlike the EQ-5D, the scoring model for the SF-6D is based on the standard gamble utility measurements. A random sample (n=836) of a general adult population from the UK was used to estimate the preferences (or health state utility values) for 249 different health states. Each participant was required to provide preferences for six health states. The range in preferences for health states for those defined by the SF-6D is narrower than the EQ-5D at 0.30 to 1.00. Participants rated their health status using a 4-week recall from the day the survey was administered.
Data analysis
We analyzed all data using STATA version 10.0. We report descriptive data as mean (standard deviation) and/ or median (interquartile range) for all baseline characteristics and primary outcomes measures. To compare the EQ-5D and the SF-6D, we used a complete case analysis approach [23, 24] . Hence, participants who had QALY estimates for both measures were included in all analyses. We also calculated summary statistics including the mean change in cost and mean QALY gain for the once-weekly and twice-weekly resistance training groups compared with the balance and tone comparator. For each participant, QALYs were estimated two ways using both the EQ-5D and SF-6D utility scores. QALYs were estimated using area under the curve analysis assuming linear change between the discrete follow-up time points [25] . The time horizon for the follow-up study was 21 months. Multiple linear regression was used to control for differences in baseline utility between the study arms to estimate the incremental QALYs [23] .
The primary outcome for our economic evaluation was the incremental cost per QALY gained of once-or twiceweekly resistance training compared with balance and tone exercises. We calculated the incremental cost per QALY (estimated from EQ-5D and SF-6D utility scores) for both once-and twice-weekly resistance trainings compared with balance and tone exercise classes (the comparator). This ratio is another expression of the differences in mean costs and health outcomes between the groups. The health benefit (i.e., QALY) difference between the groups in this case was close to zero. We used 5,000 bootstrapped replications to obtain a stable estimate of the mean difference in cost and QALYs [26] . We also used these data to generate a costutility acceptability curve to estimate the probability that once-weekly resistance training or twice-weekly resistance training is considered cost effective compared with twiceweekly balance and tone classes over a range of willingnessto-pay values [27] .
Results
Sample
Characteristics of the 155 participants who were randomized at baseline, 135 who completed the 12-month intervention study, and the 123 who consented to the 12-month follow-up study have been reported previously [16, 18, 28] . Details of the economic evaluations for the Brain Power and follow-up study have also been reported previously [18, 28] . There were no differences in the baseline characteristics for the 123 participants who took part in the follow-up study compared with the 32 of the original 155 participants who declined to participate in the follow-up study. Further, of the 123 who consented to participate in the follow-up study, 98 (80%) participants had complete data for health care resource utilization and were included in the economic evaluation. The EQ-5D utility scores were consistently higher than the SF-6D utility scores in each of the three treatment arms.
Incremental QALYs and cost-effectiveness ratios using the EQ-5D for the Brain Power intervention and follow-up study After controlling for baseline EQ-5D levels, the incremental QALY after 12 months calculated using the EQ-5D was −0.051 for the once-weekly resistance training group and −0.081 for the twice-weekly resistance training group compared with balance and tone classes (Table 1) . Based on the point estimates for total health care resource use and QALYs calculated from the EQ-5D for our base case analysis, we found that the incremental cost-utility ratio for once-weekly resistance training per QALY gained was less costly and equally effective compared with balance and tone (BAT) (Fig. 1) . The incremental cost-utility ratio for twice-weekly resistance training per QALY gained was less costly and less effective compared with BAT. The twiceweekly resistance training group showed a higher incremental QALY loss. Incremental QALYs and cost-effectiveness ratios using the SF-6D for the Brain Power intervention and follow-up study
After controlling for baseline SF-6D levels, the incremental QALY after 12 months calculated using the SF-6D was −0.144 for the once-weekly resistance training group and −0.127 for the twice-weekly resistance training group compared with balance and tone classes (Table 1) . Based on the point estimates for total health care resource use and QALYs calculated from the SF-6D for our base case analysis, we found that the incremental cost-utility ratio for once-or twice-weekly resistance training per QALY gained was less costly and less effective compared with BAT ( Fig. 1) . In contrast to the QALYs estimated from the EQ-5D, the once-weekly resistance training group showed a higher incremental QALYs loss.
Comparing the incremental cost-effectiveness ratios
The incremental SF-6D QALY was approximately three times greater than for EQ-5D QALYs for the once-weekly resistance training group compared with balance and tone exercises (Fig. 1) . The incremental SF-6D QALY was approximately 1.6 times greater than for EQ-5D QALYs for the twice-weekly resistance training group compared with balance and tone exercises. The point estimates for the ICERs estimated using SF-6D QALYs indicate that both once-and twice-weekly resistance trainings are less costly and less effective compared with balance and tone classes. The point estimates for the ICERs estimated using EQ-5D QALYs indicate that both once-and twice-weekly resistance trainings are less costly and less effective compared with balance and tone classes. However, for the EQ-5D, the point estimate for the ICER was extremely close to the yaxis approximating equal effectiveness.
Comparing cost-effectiveness acceptability curves
The difference in probability of acceptance of once-or twiceweekly resistance training compared with balance and tone classes is demonstrated by the acceptability curves (Fig. 2) . We used a lambda value of $50,000 CAD to estimate society's maximum willingness to pay for a QALY. Using the EQ-5D, once-weekly resistance training is three times more likely to be accepted compared with the SF-6D. Using the EQ-5D, twice-weekly resistance training is almost two times more likely to be accepted compared with the SF-6D.
Discussion
We found that the choice of preference-based utility instrument among a population of community-dwelling older women does matter when comparing the cost-utility of two doses of resistance training. At cessation of the follow-up study, the incremental QALY was −0.051 (EQ-5D) and −0.144 (SF-6D) for the once-weekly resistance training group and −0.081 (EQ-5D) and −0.127 (SF-6D) for the twice-weekly resistance training group compared with balance and tone classes. Although the point estimates for each ICER were in the same quadrant on the cost-effectiveness plane, the incremental QALYs estimated from the SF-6D were threefold greater than those estimated from the EQ-5D. Given the large magnitude of difference, the choice of preference-based utility instrument may substantially impact resulting health care decisions.
A novel population of community-dwelling older women Specific to older adults, few peer-reviewed studies have compared the EQ-5D and SF-6D. One recent study found that the EQ-5D and SF-6D scores were highly correlated in adults aged 45 years and older [29] . Further, individuals who were healthier had higher mean scores on the EQ-5D (p<0.001), whereas individuals who were less healthy (i.e., individuals with knee pain, osteoarthritis, back pain, rheumatoid arthritis, and hip pain) had higher mean scores on the SF-6D (p<0.001) [29] . This is not surprising given that the range of possible values from the SF-6D is 0.30-1.00 compared with the EQ-5D's range of −0.54 to 1.00 [30] . Thus, our study builds upon previous findings emphasizing that although there are strong similarities, the differences and their impacts need to be explored further.
Comparing the EQ-5D and SF-6D
Completing the EQ-5D and SF-6D are indirect approaches of preference elicitation which enable researchers to use societal health state utility values (HSUVs) for a minimal cost compared with direct elicitation techniques [31] . Generic preference-based utility instruments are often an essential component of clinical research because they offer a feasible method to assess health status, specifically to calculate QALYs for economic evaluations. Each of these preference-based utility measures provides weightings for QALYs. The EQ-5D and the SF-6D are based on different domains (i.e., health state descriptions) and valuation techniques. Resultantly, a number of studies have demonstrated, through assessing the level of agreement, that these two instruments produced different utility scores [32] [33] [34] . The SF-6D describes 18,000 discrete health states and will likely capture small changes in health status [12] compared to the EQ-5D that captures the fewest (i.e., 243 health states), but has a broader range of possible HSUVs [15] . Studies have consistently demonstrated that EQ-5D valuation scores using the time trade-off technique tend to be higher for mild states and lower for more severe states. As such, it is speculated that the estimated utility gains will be higher for the EQ-5D compared with the SF-6D (using standard gamble scores). Joore et al. [14] have recently contributed to this debate by demonstrating that this speculation is population specific. For example, the EQ-5D provided more favorable ICERs for populations with higher baseline utility and less favorable ICERs for populations with lower baseline utility. Further, they showed that using the SF-6D in patients with poor health was associated with an increased probability of accepting the ICER. Our results, however, are not directly comparable with Joore's finding because the point estimate for the ICERs falls within the southwest quadrant.
Magnitude of incremental difference in QALYs estimated from EQ-5D or SF-6D
To date, at least six articles have compared estimates of costutility according to different methods/measures of utility [35] .
Five of these six studies demonstrated that different measures result in different ICERs; these findings have potential implications for decision making about which intervention is cost effective or not. Despite the consistency of these findings, these studies have failed to highlight the magnitude of difference in incremental QALYs estimated from EQ-5D or SF-6D. After examining the ratio of incremental QALYs estimated from the EQ-5D compared with the SF-6D, we found the magnitude of difference was approximately threefold. These findings in our novel population of older women are consistent with Joore's [14] findings in four other populations (i.e., cardiovascular, pulmonary, mental, and musculoskeletal). These consistent findings across populations highlight the need for future work that explores underlying reasons for such extreme differences.
Impact on resource allocation decisions
Policy makers are faced with difficult resource allocation choices among different medical conditions (i.e., there is competition for resources for different health technologies and procedures). Economic evaluations can provide vital information to direct policy makers on how to efficiently allocate resources. To do this, there is a need to establish the population-specific validity of QALY data in the context of exercise programs among older adults. Presently, economists have used utility instruments for other chronic diseases such as rheumatoid arthritis [15] , cardiovascular disease [36] , and human immunodeficiency virus, but there is little published in the area of exercise, cognition, and falls among older adults. As such, this study provides the first insight into the potential differences use of each of these instruments will have on resource allocation. We found a threefold difference between the EQ-5D and the SF-6D with the SF-6D having a larger incremental QALY. In terms of resource allocation decision, this indicates we need to exercise caution when comparing QALYs from different instruments. The SF-6D may be more likely to show a larger loss or gain and thus more likely to result in the funding or cutting of a program compared with the EQ-5D.
Hence, further research that investigated the construct validity of these two instruments is needed before a specific recommendation for resource allocation can be made.
Limitations
Our findings should be interpreted with caution due to the following limitations. Our study sample consisted only of community-dwelling women who were cognitively intact. Therefore, we cannot say with certainty these findings are generalizable to all older women or men. This study used a complete case analysis using data from individuals where both the EQ-5D and SF-6D were completed. As such, it is possible that these data may not be fully representative of the initial 135 who completed the Brain Power study. Thus, we recommend this study be used to highlight ideas for future prospective studies to ascertain whether our present finding applied to other clinical populations.
Conclusion
The incremental QALYs estimated from the SF-6D were threefold greater than those estimated from the EQ-5D. Given the large magnitude of difference, the choice of preferencebased utility instrument may substantially impact resulting health care decisions.
